| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
15,866 |
13,708 |
$779K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
6,450 |
5,772 |
$448K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
3,866 |
3,773 |
$297K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
8,051 |
7,191 |
$278K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
19,854 |
9,363 |
$230K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
3,558 |
3,434 |
$152K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,837 |
1,790 |
$148K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
8,010 |
3,836 |
$105K |
| 99383 |
|
1,152 |
1,123 |
$95K |
| 99381 |
|
1,395 |
1,338 |
$84K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
819 |
798 |
$72K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
8,636 |
7,929 |
$68K |
| 99382 |
|
802 |
777 |
$65K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
660 |
644 |
$54K |
| 99384 |
|
568 |
547 |
$50K |
| 99429 |
|
1,899 |
1,830 |
$49K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,599 |
3,418 |
$47K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
248 |
125 |
$35K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
530 |
520 |
$30K |
| 87807 |
|
2,414 |
2,316 |
$25K |
| 99215 |
Prolong outpt/office vis |
333 |
324 |
$25K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
541 |
487 |
$23K |
| 92551 |
|
2,892 |
2,653 |
$22K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
917 |
867 |
$17K |
| 90461 |
|
6,972 |
6,171 |
$13K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
160 |
160 |
$6K |
| 99401 |
|
1,558 |
1,287 |
$6K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
505 |
487 |
$6K |
| 99000 |
|
596 |
574 |
$5K |
| 90833 |
Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) |
52 |
49 |
$3K |
| 83655 |
|
281 |
268 |
$3K |
| 94760 |
|
3,085 |
2,566 |
$2K |
| 90836 |
|
26 |
26 |
$2K |
| 92552 |
|
103 |
99 |
$2K |
| 99442 |
|
158 |
148 |
$2K |
| 94010 |
|
82 |
49 |
$2K |
| 96160 |
|
1,402 |
1,331 |
$1K |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
442 |
425 |
$1K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
163 |
160 |
$992.32 |
| 96136 |
|
51 |
51 |
$848.64 |
| 96137 |
|
51 |
51 |
$748.88 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
25 |
25 |
$637.84 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
49 |
48 |
$605.00 |
| 90677 |
|
2,179 |
2,069 |
$553.16 |
| 85018 |
|
361 |
335 |
$549.34 |
| 69210 |
|
16 |
16 |
$541.14 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
59 |
36 |
$508.62 |
| 99050 |
|
32 |
30 |
$403.92 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
13 |
13 |
$383.24 |
| 90619 |
|
66 |
66 |
$167.83 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
21 |
13 |
$165.06 |
| 99080 |
|
58 |
58 |
$50.00 |
| 90697 |
|
1,620 |
1,556 |
$29.96 |
| 96161 |
|
523 |
476 |
$18.11 |
| 90688 |
|
252 |
251 |
$18.07 |
| 99072 |
|
567 |
475 |
$15.00 |
| J7626 |
Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg |
14 |
14 |
$12.12 |
| 90698 |
|
1,435 |
1,388 |
$6.19 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
88 |
88 |
$3.40 |
| 91307 |
|
28 |
26 |
$0.22 |
| 90670 |
|
1,952 |
1,898 |
$0.05 |
| 90656 |
|
222 |
222 |
$0.03 |
| 90661 |
|
14 |
14 |
$0.01 |
| 90696 |
|
382 |
365 |
$0.00 |
| 90680 |
|
2,758 |
2,637 |
$0.00 |
| 96127 |
|
258 |
244 |
$0.00 |
| 36416 |
|
404 |
375 |
$0.00 |
| 90686 |
|
636 |
632 |
$0.00 |
| 90723 |
|
64 |
63 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
236 |
230 |
$0.00 |
| 90651 |
|
348 |
330 |
$0.00 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
52 |
42 |
$0.00 |
| 90716 |
|
220 |
217 |
$0.00 |
| 90744 |
|
307 |
293 |
$0.00 |
| 90620 |
|
17 |
17 |
$0.00 |
| 97802 |
|
136 |
118 |
$0.00 |
| 90707 |
|
228 |
218 |
$0.00 |
| 94664 |
|
616 |
587 |
$0.00 |
| 99173 |
|
3,426 |
3,207 |
$0.00 |
| 99051 |
|
34 |
34 |
$0.00 |
| 90710 |
|
1,083 |
1,040 |
$0.00 |
| 90734 |
|
306 |
288 |
$0.00 |
| 90700 |
|
609 |
594 |
$0.00 |
| 90633 |
|
1,780 |
1,737 |
$0.00 |
| 90715 |
|
295 |
278 |
$0.00 |
| 90648 |
|
732 |
710 |
$0.00 |
| 90681 |
|
38 |
38 |
$0.00 |